385 related articles for article (PubMed ID: 34784922)
21. Progress Toward Measles Elimination - Western Pacific Region, 2013-2017.
Hagan JE; Kriss JL; Takashima Y; Mariano KML; Pastore R; Grabovac V; Dabbagh AJ; Goodson JL
MMWR Morb Mortal Wkly Rep; 2018 May; 67(17):491-495. PubMed ID: 29723171
[TBL] [Abstract][Full Text] [Related]
22. Progress in global measles control, 2000-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(4):73-8. PubMed ID: 22298303
[TBL] [Abstract][Full Text] [Related]
23. Mapping the distribution of zero-dose children to assess the performance of vaccine delivery strategies and their relationships with measles incidence in Nigeria.
Utazi CE; Aheto JMK; Wigley A; Tejedor-Garavito N; Bonnie A; Nnanatu CC; Wagai J; Williams C; Setayesh H; Tatem AJ; Cutts FT
Vaccine; 2023 Jan; 41(1):170-181. PubMed ID: 36414476
[TBL] [Abstract][Full Text] [Related]
24. The impact of supplementary immunization activities on measles transmission dynamics and implications for measles elimination goals: A mathematical modelling study.
Shen M; Sun X; Xiao Y; Liu Y; Wang C; Wang Z; Rong L; Peng Z
J Theor Biol; 2022 Nov; 551-552():111242. PubMed ID: 35952756
[TBL] [Abstract][Full Text] [Related]
25. Progress Toward Measles Elimination - Nepal, 2007-2014.
Khanal S; Sedai TR; Choudary GR; Giri JN; Bohara R; Pant R; Gautam M; Sharapov UM; Goodson JL; Alexander J; Dabbagh A; Strebel P; Perry RT; Bah S; Abeysinghe N; Thapa A
MMWR Morb Mortal Wkly Rep; 2016 Mar; 65(8):206-10. PubMed ID: 26937619
[TBL] [Abstract][Full Text] [Related]
26. Measles outbreaks and progress toward measles preelimination --- African region, 2009-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Apr; 60(12):374-8. PubMed ID: 21451448
[TBL] [Abstract][Full Text] [Related]
27. Exploring the subnational inequality and heterogeneity of the impact of routine measles immunisation in Africa.
Echeverria-Londono S; Hartner AM; Li X; Roth J; Portnoy A; Sbarra AN; Abbas K; Ferrari M; Fu H; Jit M; Ferguson NM; Gaythorpe KAM
Vaccine; 2022 Nov; 40(47):6806-6817. PubMed ID: 36244882
[TBL] [Abstract][Full Text] [Related]
28. Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20.
Prosperi C; Thangaraj JWV; Hasan AZ; Kumar MS; Truelove S; Kumar VS; Winter AK; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Soman B; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sharma NP; Sharma S; Varghese A; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Chonker SK; Cutts FT; Sangal L; Mehendale SM; Sapkal GN; Gupta N; Hayford K; Moss WJ; Murhekar MV
Vaccine; 2023 Jan; 41(2):486-495. PubMed ID: 36481106
[TBL] [Abstract][Full Text] [Related]
29. Challenges Addressing Inequalities in Measles Vaccine Coverage in Zambia through a Measles-Rubella Supplementary Immunization Activity during the COVID-19 Pandemic.
Yang Y; Kostandova N; Mwansa FD; Nakazwe C; Namukoko H; Sakala C; Bobo P; Masumbu PK; Nachinga B; Ngula D; Carcelen AC; Prosperi C; Winter AK; Moss WJ; Mutembo S
Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992192
[TBL] [Abstract][Full Text] [Related]
30. The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya.
Mburu CN; Ojal J; Chebet R; Akech D; Karia B; Tuju J; Sigilai A; Abbas K; Jit M; Funk S; Smits G; van Gageldonk PGM; van der Klis FRM; Tabu C; Nokes DJ; ; Scott J; Flasche S; Adetifa I
BMC Med; 2021 Feb; 19(1):35. PubMed ID: 33531015
[TBL] [Abstract][Full Text] [Related]
31. Progress toward measles elimination--Western Pacific Region, 2009-2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Jun; 62(22):443-7. PubMed ID: 23739338
[TBL] [Abstract][Full Text] [Related]
32. Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection.
Abbas K; Procter SR; van Zandvoort K; Clark A; Funk S; Mengistu T; Hogan D; Dansereau E; Jit M; Flasche S;
Lancet Glob Health; 2020 Oct; 8(10):e1264-e1272. PubMed ID: 32687792
[TBL] [Abstract][Full Text] [Related]
33. Scheduling of measles vaccination in low-income countries: projections of a dynamic model.
Bauch CT; Szusz E; Garrison LP
Vaccine; 2009 Jun; 27(31):4090-8. PubMed ID: 19410622
[TBL] [Abstract][Full Text] [Related]
34. Global control and regional elimination of measles, 2000-2012.
Perry RT; Gacic-Dobo M; Dabbagh A; Mulders MN; Strebel PM; Okwo-Bele JM; Rota PA; Goodson JL;
MMWR Morb Mortal Wkly Rep; 2014 Feb; 63(5):103-7. PubMed ID: 24500289
[TBL] [Abstract][Full Text] [Related]
35. Progress towards elimination of measles in Kenya, 2003-2016.
Kisangau N; Sergon K; Ibrahim Y; Yonga F; Langat D; Nzunza R; Borus P; Galgalo T; Lowther SA
Pan Afr Med J; 2018; 31():65. PubMed ID: 31007812
[TBL] [Abstract][Full Text] [Related]
36. Differential health impact of intervention programs for time-varying disease risk: a measles vaccination modeling study.
Portnoy A; Hsieh YL; Abbas K; Klepac P; Santos H; Brenzel L; Jit M; Ferrari M
BMC Med; 2022 Mar; 20(1):113. PubMed ID: 35260139
[TBL] [Abstract][Full Text] [Related]
37. The cost-effectiveness of supplementary immunization activities for measles: a stochastic model for Uganda.
Bishai D; Johns B; Nair D; Nabyonga-Orem J; Fiona-Makmot B; Simons E; Dabbagh A
J Infect Dis; 2011 Jul; 204 Suppl 1(Suppl 1):S107-15. PubMed ID: 21666151
[TBL] [Abstract][Full Text] [Related]
38. Measles vaccine coverage estimates in an outbreak three years after the nation-wide campaign in China: implications for measles elimination, 2013.
Ma C; Li F; Zheng X; Zhang H; Duan M; Yang Y; Hao L; Su Q; Rodewald L; Guo B; Xiao S; Wang H; Li L; Li J; Luo H; Gao L
BMC Infect Dis; 2015 Jan; 15():23. PubMed ID: 25608672
[TBL] [Abstract][Full Text] [Related]
39. Measles Vaccine Coverage and Disease Outbreaks: A Systematic Review of the Early Impact of COVID-19 in Low and Lower-Middle Income Countries.
Packham A; Taylor AE; Karangwa MP; Sherry E; Muvunyi C; Green CA
Int J Public Health; 2024; 69():1606997. PubMed ID: 38725903
[No Abstract] [Full Text] [Related]
40. Accelerating measles elimination and strengthening routine immunization services in Guizhou Province, China, 2003-2009.
Zuo S; Cairns L; Hutin Y; Liang X; Tong Y; Zhu Q; Zhang D; Lee LA; Strebel P; Quick L
Vaccine; 2015 Apr; 33(17):2050-5. PubMed ID: 25769207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
